Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

LIN US Equity

Linde PLCMaterials · Industrial Inorganic Chemicals · CIK 1707925 · FY ends Dec 31
$478.71
+4.38 (+0.92%)
USD · as of 2026-08-18 · marketstack
1 registered study · 0 active

Studies where LIN is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

1 observational

Held by 28 tracked-famous managers (LONE PINE CAPITAL LLC, Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, Artisan Partners Limited Partnership, MARSHALL WACE, LLP, +23 more) · FINRA short interest 2.6 days to cover (settled 2026-07-31) · government filings 180d: 0 congress / 3 executive

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
MIND Score for Prolonged Mechanical VentilationNCT02255058observationalTo evaluate the psychometric performance of the MIND score in terms of validity, reliability and sensitivity to change over timeCompletedOther: No interventionFunctional Test, COPD, Neuromuscular Disorders, Mechanical Ventilation, Weaning, Disability129Dec 2014actual2015-03-02

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19